Biohack Blueprint · DoNotAge Intelligence
Source-linked DoNotAge conference coverage with annual event hubs, lecture analyses, scientists, original sources and explicit evidence-state labels.
Nicolás Cherñavsky’s DoNotAge Conference 2026 rejuvenation update, with the key distinction preserved: the ICR programme is still an ongoing preclinical replication effort.
Conference talk analysisAndrei Seluanov’s DoNotAge Conference 2026 discussion of LINE-1, SIRT6 and inflammaging, mapped to published mouse research from 2019 through 2026.
Conference talk analysisRebecca Sumner’s DoNotAge Conference 2026 presentation on CDK4/6, cell division and inflammatory regulation, currently classified as conference-stage mechanistic research.
Conference talk analysisDavid Weinkove’s DoNotAge Conference 2026 discussion of the methodological and practical challenges that make ageing clinical trials unusually difficult.
Conference talk analysisThe 2026 conference quercetin/blood-pressure presentation linked to NCT06230861, a UCLan trial that lists DoNotAge.org as collaborator.
Conference talk analysisConstanza Cortes presented a DoNotAge-funded aged-mouse study testing the prosaposin-derived peptide PS18 as an exercise-mimetic candidate. Published mouse data support a muscle-to-brain signal, but whether PSAP itself is genuinely exercise-responsive...
Conference talk analysisCiara Angeli Juan’s 2026 conference presentation on exercise, SIRT1, quercetin and DNA damage, linked to an Ulster University preprint record.
Conference talk analysisSergej Ostojic’s DoNotAge Conference 2026 presentation on creatine, bioenergetics and healthy ageing, with the evidence states kept separate.
Conference talk analysisJoanna Ward’s 2026 DoNotAge conference presentation on inflammaging, ASCVD and NLRP3, connected to her DoNotAge-funded BSRA research grant.
Conference talk analysisConference-stage coverage of Søren Wilton Kudahl-Laursen’s DoNotAge Conference 2026 presentation on spermidine, ageing and muscle stem-cell proliferation.
Conference talk analysisConference-stage analysis of the DoNotAge Conference 2026 material covering SIRT6, DNA repair, epigenetic maintenance, fucoidan and related experimental research.
Conference talk analysisThe complete DoNotAge Conference 2026 research map: speakers, talks, evidence status, human trials, grants, preclinical projects, the PS18 exercise-mimetic study and the DoNotAge Performance launch.
Conference hubContinue the cluster
Move from news or conference coverage into the underlying research, people and policy pillars.
See the projects and the exact relationship to DoNotAge.
Research trackerTrace speakers and investigators to the relevant project or talk.
Scientist directoryTimestamped shipping, returns, subscriptions, guarantees and testing guidance.
Practical guide